Nuria Prim
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
Addressing carbapenemase-producing extensively drug-resistant Pseudomonas aeruginosa: the potential of cefiderocol and ceftazidime/avibactam plus aztreonam therapy.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: November 15, 2024
Synergistic efficacy of ceftazidime/avibactam and aztreonam against carbapenemase-producing Pseudomonas aeruginosa: insights from the hollow-fiber infection model.
Journal: Infectious diseases (London, England)
Published: August 30, 2024
Pharmacodynamic interaction of apotransferrin and anti-pseudomonal antibiotics against extensively drug-resistant Pseudomonas aeruginosa in a dynamic PK/PD model.
Journal: International journal of antimicrobial agents
Published: August 09, 2024
Penetration of linezolid into the pleural cavity in critically ill patients with proven or suspected Gram-positive bacterial infections: a retrospective pharmacokinetic study.
Journal: The Journal of antimicrobial chemotherapy
Published: May 27, 2024
New Predictive Equation for the Estimation of Plasma Concentrations of Formed Colistin in Patients Treated With Colistimethate Sodium for Multidrug-Resistant Gram-Negative Bacterial Infections.
Journal: Therapeutic drug monitoring
Published: November 17, 2023
Colistin plasma concentrations are not associated with better clinical outcomes in patients with pneumonia caused by extremely drug-resistant Pseudomonas aeruginosa.
Journal: Microbiology spectrum
Published: November 09, 2023
Changes in Group A Streptococcus emm Types Associated with Invasive Infections in Adults, Spain, 2023.
Journal: Emerging infectious diseases
Published: October 25, 2023
Ampicillin-resistant and vancomycin-susceptible Enterococcus faecium bacteremia: a clinical narrative review.
Journal: Expert review of anti-infective therapy
Published: June 09, 2023
Antibiotic Susceptibility and Clarithromycin Resistance Determinants in Helicobacter pylori in the Northeast of Spain: A One-Year Prospective Study.
Journal: Antibiotics (Basel, Switzerland)
Published: January 10, 2023
Comparative Analysis of Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae.
Journal: Antibiotics (Basel, Switzerland)
Published: October 03, 2022
Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence.
Journal: Antibiotics (Basel, Switzerland)
Published: September 28, 2022
Pharmacokinetics/pharmacodynamics and therapeutic drug monitoring of ceftazidime/avibactam administered by continuous infusion in patients with MDR Gram-negative bacterial infections.
Journal: The Journal of antimicrobial chemotherapy
Published: September 26, 2022
Last Updated: 09/26/2026